Merck

Collaboration to focus on oral and injectable formulations of Lenacapavir and Islatravir

In Express Pharma’s Women’s Day Special issue, some industry observers and pharma stakeholders share insights on opportunities,…

The acquisition to expand Merck’s lipid manufacturing expertise and mRNA capabilities for vaccines, treatments and diagnostics

Approvals in three types of cancer are based on the PAOLA-1, PROfound and POLO Phase 3 Trials

Merck will accelerate the development of CD24Fc, a candidate for the treatment of patients with severe and critical COVID-19

KEYTRUDA is the first anti-PD-1 therapy approved for adult patients with relapsed or refractory cHL after frontline therapy

Belén Garijo will take charge as Chair of the Executive Board of Merck from Stefan Oschmann in 2021

Johnson & Johnson maintained its top position with MCap growth of 7.2 per cent on a QoQ basis

The FDA's complete response letter cited lack of sufficient evidence that the Keytruda-Lenvima combination therapy had a…

The deals cover Roche’s arthritis drug RoActemra and Merck’s multiple sclerosis drug Rebif - both seen as potential COVID-19…